Profit Investment Management, LLC Global Blood Therapeutics, Inc. Transaction History

Profit Investment Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 08, 2021	SELL	$25.48 - $37.34 $933,357 - $1.37 Million	-36,631 Closed	0 $0
Q1 2021 Apr 14, 2021	SELL	$38.94 - $50.85 $216,701 - $282,980	-5,565 Reduced 13.19%	36,631 $1.49 Million
Q3 2020 Nov 09, 2020	BUY	$52.76 - $74.49 $128,417 - $181,308	2,434 Added 6.12%	42,196 $2.33 Million
Q2 2020 Jul 16, 2020	SELL	$48.73 - $81.82 $346,519 - $581,822	-7,111 Reduced 15.17%	39,762 $2.51 Million
Q4 2019 Jan 15, 2020	BUY	$45.7 - $81.86 $945,852 - $1.69 Million	20,697 Added 79.07%	46,873 $3.73 Million
Q3 2019 Oct 17, 2019	BUY	$45.35 - $57.91 $1.19 Million - $1.52 Million	26,176 New	26,176 $1.27 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Profit Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Profit Investment Management, LLC with notifications on news.